JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB26

Anti-p53 抗体 [PAb 240]

Anti-p53 antibody [PAb 240]

4

(56 Reviews)

|

(530 Publications)

Anti-p53 antibody [PAb 240] (ab26) is a mouse monoclonal antibody detecting p53 in Western Blot, IP, ICC/IF. Suitable for Human, Mouse.

- KO validated for confirmed specificity
- Over 400 publications
- Trusted since 1998

別名を表示する

P53, Trp53, Tp53, Cellular tumor antigen p53, Tumor suppressor p53

8 Images
Western blot - Anti-p53 antibody [PAb 240] (AB26)
  • WB

Supplier Data

Western blot - Anti-p53 antibody [PAb 240] (AB26)

Lanes 1-6 : Merged (red and green) signal.

ab26 was shown to specifically react with p53 in wild type HCT116 cells treated with irinotecan. No band was observed in p53 knockout HCT116 cells. Wild-type and p53 knockout samples, positive and negative controls were subjected to SDS-PAGE. ab26 and ab181602 (loading control to GAPDH) were diluted 5 μg/mL and 1/10,000 respectively and incubated overnight at 4°C. Blots were developed with goat anti-rabbit IgG (H + L) and goat anti-mouse IgG (H + L) secondary antibodies at 1/10,000 dilution for 1 h at room temperature before imaging.

Wild-type and p53 knockout HCT116 cell lysates were kindly provided by a collaborator.

All lanes:

Western blot - Anti-p53 antibody [PAb 240] (ab26) at 5 µg/mL

Lane 1:

Wild-type HCT116 cell lysate at 30 µg

Lane 2:

Wild-type HCT116 + irinotecan (10 µM, 24 hours) cell lysate at 30 µg

Lane 3:

p53 knockout HCT116 cell lysate at 30 µg

Lane 4:

p53 knockout HCT116 + irinotecan (10 µM, 24 hours) cell lysate at 30 µg

Lane 5:

A431 cell lysate (positive control) at 20 µg

Lane 6:

Saos-2 cell lysate (negative control) at 20 µg

Predicted band size: 43 kDa

Observed band size: 53 kDa

false

Immunocytochemistry/ Immunofluorescence - Anti-p53 antibody [PAb 240] (AB26)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-p53 antibody [PAb 240] (AB26)

ab26 stained in A431 cells. Cells were fixed with 4% paraformaldehyde (10min) at room temperature and incubated with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% triton for 1h at room temperature to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with ab26 at 1μg/ml and ab6046 (Rabbit polyclonal to beta tubulin) at 1ug/ml overnight at +4°C. The secondary antibodies were ab150177 (colored green) used at 1 ug/ml and ab150087 (pseudo-colored red) used at 2ug/ml for 1hour at room temperature. DAPI was used to stain the cell nuclei (colored blue) at a concentration of 1.43μM for 1hour at room temperature.

Immunoprecipitation - Anti-p53 antibody [PAb 240] (AB26)
  • IP

AbReview41852****

Immunoprecipitation - Anti-p53 antibody [PAb 240] (AB26)

p53 was immunoprecipitated from 7x106 HCT116 (human colon carcinoma cell line) cells with ab26 at 1/150 dilution. Western blot was performed from the immunoprecipitate using anti-p53 antibody. Donkey Anti-Mouse IgG H&L (Alexa Fluor® 750) preadsorbed (ab175739) was used as secondary antibody at 1/5000 dilution.

Lane 1 : HCT116 whole cell lysate 10 μg (Input).

Lane 2 : ab207799 IP in etoposide treated HCT116 whole cell lysate.

Lane 3 : ab207799 IP in etoposide treated HCT116 p53-/- whole cell lysate (negative control).

All lanes:

Anti p53 antibody

Secondary

All lanes:

Immunoprecipitation - Donkey Anti-Mouse IgG H&L (Alexa Fluor® 750) preadsorbed (<a href='/products/secondary-antibodies/donkey-mouse-igg-h-l-alexa-fluor-750-preadsorbed-ab175739'>ab175739</a>) at 1/5000 dilution

Predicted band size: 43 kDa

false

Western blot - Anti-p53 antibody [PAb 240] (AB26)
  • WB

AbReview11453****

Western blot - Anti-p53 antibody [PAb 240] (AB26)

All lanes:

Western blot - Anti-p53 antibody [PAb 240] (ab26) at 1/2000 dilution

Lane 1:

Human breast cancer cell-line, MCF7 cells (p53 WT), whole cell lysate at 20 µg

Lane 2:

Human breast cancer cell-line, MDA231 cells (p53 Mutant), whole cell lysate at 20 µg

Secondary

All lanes:

HRP conjugated donkey anti-mouse antibody at 1/5000 dilution

Predicted band size: 43 kDa

Observed band size: 53 kDa,72 kDa

true

Exposure time: 10s

This image is courtesy of an Abreview submitted by Dr Cherie Blenkiron

Western blot - Anti-p53 antibody [PAb 240] (AB26)
  • WB

Project10191****

Western blot - Anti-p53 antibody [PAb 240] (AB26)

All lanes:

Western blot - Anti-p53 antibody [PAb 240] (ab26) at 5 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µg

Lane 2:

Hela Whole Cell Lysate - Bleomycin Treated (40U/ml) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/5000 dilution

Predicted band size: 43 kDa

true

Exposure time: 4min

Western blot - Anti-p53 antibody [PAb 240] (AB26)
  • WB

Lab

Western blot - Anti-p53 antibody [PAb 240] (AB26)

Lanes 1-2 : 1% BSA blocking buffer

Lanes 3-4 : 3% Milk blocking buffer

We recommend using 3% milk as the blocking agent for Western blot.

Lanes 1 - 2:

Western blot - Anti-p53 antibody [PAb 240] (ab26) at 1 µg/mL

Lanes 3 - 4:

Western blot - Anti-p53 antibody [PAb 240] (ab26) at 5 µg/mL

All lanes:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µg

Secondary

All lanes:

Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/5000 dilution

Predicted band size: 43 kDa

true

Exposure time: 4min

Western blot - Anti-p53 antibody [PAb 240] (AB26)
  • WB

Lab

Western blot - Anti-p53 antibody [PAb 240] (AB26)

This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab26 overnight at 4°C. Antibody binding was detected using an anti-mouse HRP secondary antibody (ab97040), and visualised using ECL development solution ab133406.

All lanes:

Western blot - Anti-p53 antibody [PAb 240] (ab26) at 1 µg/mL

All lanes:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/50000 dilution

Predicted band size: 43 kDa

Observed band size: 53 kDa

true

Exposure time: 8min

Western blot - Anti-p53 antibody [PAb 240] (AB26)
  • WB

Unknown

Western blot - Anti-p53 antibody [PAb 240] (AB26)

Primary : All Lanes : Anti-p53 antibody (ab26) at 5 μg/mL. Lane 1 : MW marker. Lane 2 : NIH/3T3 cells treated with vehicle for 24 hours. Lane 3 : NIH/3T3 cells treated with 1 μM doxorubicin for 24 hours Secondary : All Lanes : HRP-conjugated VeriBlot anti-Mouse IgG (ab131368) 1 : 1000. Lysates at 20 μg/lane. Performed under denaturing conditions. Developed using ECL technique. Blocking buffer : 5% milk in PBS.

All lanes:

Western blot - Anti-p53 antibody [PAb 240] (ab26)

Predicted band size: 43 kDa

false

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

PAb 240

アイソタイプ

IgG1

軽鎖のタイプ

kappa

キャリアフリー

No

交差種

Mouse, Human

アプリケーション

IP, ICC/IF, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

エピトープ

The epitope has been mapped to between amino acids 212 and 217 on human p53 (PMID: 1376364).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p>Please note that expression of target protein may be very low without stimulation/treatment (e.g. DNA damaging agent). We recommend using 3% milk as the blocking agent for Western blot.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "0.5-1 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p>Please note that expression of target protein may be very low without stimulation/treatment (e.g. DNA damaging agent). We recommend using 3% milk as the blocking agent for Western blot.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "0.5-1 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Chinese hamster": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Cow": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Dog": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Monkey": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Syrian hamster": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

製品の詳細

ab26 has been knockout validated in Western blot. The expected band was seen in wild type HCT116 cells treated with the DNA damaging agent irinotecan and no band was seen in TP53 knockout HCT116 cells.

Product Specifications
Anti-p53 antibody [PAb 240] (ab26) is a mouse monoclonal antibody and is validated for use in ICC/IF, IP, WB in human, mouse samples.
Anti-p53 antibody [PAb 240] (ab26) specifically detects p53 (UniProt ID: P04637; Molecular weight: 44kDa) and is sold in 100 µg selling sizes.

Quality and Validation
Abcam's high quality validation processes ensure Anti-p53 antibody [PAb 240] (ab26) has high sensitivity and specificity.
The specificity of Anti-p53 antibody [PAb 240] (ab26) has been confirmed by testing in knockout samples.
Anti-p53 antibody [PAb 240] (ab26) has been cited over 403 times in peer reviewed journals and is trusted by the scientific community.
Anti-p53 antibody [PAb 240] (ab26) has 54 independent reviews from customers.

Related Products
Conjugation-ready, carrier free format available for antibody clone PAb 240 - ab185238.

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification
バッファー組成
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 6.97% L-Arginine
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The protein p53 also known as TP53 or tumor protein p53 has a molecular weight of approximately 53 kDa. It acts as a transcription factor and plays a major role in cell cycle regulation apoptosis and maintaining genomic stability. This protein mainly expresses in the nucleus of cells and acts as a critical regulator of cellular responses to stress signals including DNA damage. Scientists commonly use p53 antibodies in various assays like western blot and p53 immunofluorescence to detect and study its expression and functional status in cells.
Biological function summary

P53 functions to control cell division and apoptosis serving as a guardian of the genome by preventing mutation accumulation. It does not form part of a larger complex under normal conditions but interacts with various other molecules to execute its functions. p53 can activate or suppress the transcription of numerous genes involved in cell cycle arrest DNA repair and programmed cell death allowing it to halt the progression of damaged cells and trigger repair mechanisms or eliminate those that cannot be repaired.

Pathways

P53 acts within several key biological pathways such as the p53 signaling pathway and the intrinsic apoptotic pathway. Its activity involves interaction with proteins like MDM2 which regulates p53 through ubiquitin-mediated degradation and ATM kinase which phosphorylates p53 in response to DNA damage. These interactions ensure appropriate cellular responses during stress and are vital for maintaining homeostasis.

P53 mutation or inactivation is often associated with the development of cancer given its role in controlling cell division and preventing tumor formation. Specifically its dysfunction has been linked to cancers such as breast cancer and lung cancer. Additionally p53 can interact with other mutant proteins like Ras compounding mutations that contribute to tumor progression and aggressive cancer phenotypes. Understanding these interactions and the status of p53 can be important in developing targeted cancer therapies.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed : 19556538, PubMed : 20673990, PubMed : 22726440). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Negatively regulates cell division by controlling expression of a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (By similarity). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (By similarity). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression (By similarity). Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis, but seems to have to effect on cell-cycle regulation. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed : 24051492).
See full target information Tp53

文献 (530)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 16:710 PubMed41057318

2025

CTRP9 as a myokine mitigates sarcopenia via the LAMP-2A/NLRP3 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Linxi Li,Anju Zuo,Ruoyu Yin,Qiangqiang Liu,Chen Liu,Na Li,Dan Xu,Shaomeng Zhang,Jiarui Li,Shengyun Lei,Shiyan Ruan,Tingting Li,Yuan Guo

PloS one 20:e0332761 PubMed41060973

2025

SAT1 promotes the progression of OA by regulating TRIM33-mediated p53 acetylation to enhance ferroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Jiexiang Yang,Jing Jiang,Jing Wang,Lin Luo

Nature communications 16:8726 PubMed41028714

2025

Regulation of NSL by TAF4A is critical for genome stability and quiescence of muscle stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Angelina M Georgieva,Krishna Sreenivasan,Dong Ding,Clementine Villeneuve,Sara A Wickström,Stefan Günther,Carsten Kuenne,Ulrich Gärtner,Xinyue Guo,Yonggang Zhou,Xuejun Yuan,Thomas Braun

Neoplasma 72:229-241 PubMed40958520

2025

Synergistic effects of histone deacetylase inhibitor chidamide and BCL-2 inhibitor venetoclax in activating the p53 pathway in diffuse large B-cell lymphoma.

Applications

Unspecified application

Species

Unspecified reactive species

Zhengrong Song,Zhengyan Song,Liyuan Ren,Xinzhi Han,Xuejun Zhang,Shupeng Wen

International journal of biological sciences 21:5476-5495 PubMed40959275

2025

Increased CAPG inhibits ferroptosis to drive tumor proliferation and sorafenib resistance in hepatocellular carcinoma via the WDR74-p53-SLC7A11 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Bing Quan,Fan Yao,Wenfeng Liu,Bei Tang,Miao Li,Shenxin Lu,Jinghuan Li,Rongxin Chen,Zhenggang Ren,Xin Yin

Journal of nanobiotechnology 23:575 PubMed40830790

2025

Engineered MEVs for photoreceptor-targeted delivery of USP25 to alleviate diabetic retinopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Yaoxiang Sun,Shenyuan Chen,Xiaoyuan Qi,Yuntong Sun,Zhengmei Jiang,Jie Chang,Yongjun Ma,Jin Huang,Benshuai You,Fengtian Sun

Open life sciences 20:20251151 PubMed40822973

2025

Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Liqin Sheng,Yiming Wu,Fei Shen,Chenzhou Xu

International journal of molecular medicine 56: PubMed40641112

2025

TNF‑α induces premature senescence in tendon stem cells via the NF‑κB and p53/p21/cyclin E/CDK2 signaling pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Hua Guo,Haixia Cao,Qian Lu,Zhifeng Gu,Guijuan Feng

Signal transduction and targeted therapy 10:212 PubMed40624014

2025

Transferrin receptor 1 nuclear translocation facilitates tumor progression via p53-mediated chromatin interactions and genome-wide alterations.

Applications

Unspecified application

Species

Unspecified reactive species

Yaxin Hou,Guoheng Tang,Qizhi Wang,Meng Zhou,Ran Xu,Xuehui Chen,Guizhi Shi,Zhuoran Wang,Xiyun Yan,Jie Zhuang,Kelong Fan

Bioactive materials 52:541-563 PubMed40599343

2025

Hypoxia preconditioned MSC exosomes attenuate high-altitude cerebral edema via the miR-125a-5p/RTEF-1 axis to protect vascular endothelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jia-Chen Zuo,Jun Liang,Nan Hu,Bin Yao,Qi-Jian Zhang,Xiao-Li Zeng,Ling-Jie Zhang,Xu Zhang,Zhe-Han Chang,Chong Chen,Xin-Jian Yan,Wen-Wei Shao,Ping Zhu,Xiao-Hong Li
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com